186 related articles for article (PubMed ID: 34638475)
1. Type 2 Diabetes Mellitus and Clinicopathological Tumor Characteristics in Women Diagnosed with Breast Cancer: A Systematic Review and Meta-Analysis.
Zhang F; de Haan-Du J; Sidorenkov G; Landman GWD; Jalving M; Zhang Q; de Bock GH
Cancers (Basel); 2021 Oct; 13(19):. PubMed ID: 34638475
[TBL] [Abstract][Full Text] [Related]
2. Breastfeeding and breast cancer risk by receptor status--a systematic review and meta-analysis.
Islami F; Liu Y; Jemal A; Zhou J; Weiderpass E; Colditz G; Boffetta P; Weiss M
Ann Oncol; 2015 Dec; 26(12):2398-407. PubMed ID: 26504151
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological characteristics and prognosis of breast cancer patients with type 2 diabetes mellitus.
He DE; Bai JW; Liu J; DU CW; Huang WH; Zhang GJ
Mol Clin Oncol; 2015 May; 3(3):607-612. PubMed ID: 26137275
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer subtypes as defined by the estrogen receptor (ER), progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2) among women with invasive breast cancer in California, 1999-2004.
Parise CA; Bauer KR; Brown MM; Caggiano V
Breast J; 2009; 15(6):593-602. PubMed ID: 19764994
[TBL] [Abstract][Full Text] [Related]
5. Predictive factors associated with axillary lymph node metastases in T1a and T1b breast carcinomas: analysis in more than 900 patients.
Rivadeneira DE; Simmons RM; Christos PJ; Hanna K; Daly JM; Osborne MP
J Am Coll Surg; 2000 Jul; 191(1):1-6; discussion 6-8. PubMed ID: 10898177
[TBL] [Abstract][Full Text] [Related]
6. Prognostic and clinicopathological value of Twist expression in breast cancer: A meta-analysis.
Qiao W; Jia Z; Liu H; Liu Q; Zhang T; Guo W; Li P; Deng M; Li S
PLoS One; 2017; 12(10):e0186191. PubMed ID: 29016671
[TBL] [Abstract][Full Text] [Related]
7. Prognostic and clinical significance of syndecan-1 expression in breast cancer: A systematic review and meta-analysis.
Qiao W; Liu H; Guo W; Li P; Deng M
Eur J Surg Oncol; 2019 Jul; 45(7):1132-1137. PubMed ID: 30598194
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological significance of Sox2 expression in patients with breast cancer: a meta-analysis.
Zheng Y; Qin B; Li F; Xu S; Wang S; Li L
Int J Clin Exp Med; 2015; 8(12):22382-92. PubMed ID: 26885218
[TBL] [Abstract][Full Text] [Related]
9. Worse outcome in breast cancer with higher tumor-infiltrating FOXP3+ Tregs : a systematic review and meta-analysis.
Shou J; Zhang Z; Lai Y; Chen Z; Huang J
BMC Cancer; 2016 Aug; 16(1):687. PubMed ID: 27566250
[TBL] [Abstract][Full Text] [Related]
10. Breast Cancer Subtype as a Predictor of Lymph Node Metastasis according to the SEER Registry.
Mattes MD; Bhatia JK; Metzger D; Ashamalla H; Katsoulakis E
J Breast Cancer; 2015 Jun; 18(2):143-8. PubMed ID: 26155290
[TBL] [Abstract][Full Text] [Related]
11. [Analysis of risk factors of axillary lymph node metastasis and prognosis in T1 breast cancer: a large-scale retrospective study based on the SEER database].
Wang WY; Meng XZ; Li N; Zeng HM; Liu JX; Feng KX; Wang PL; Wang X
Zhonghua Yi Xue Za Zhi; 2021 Jul; 101(27):2152-2158. PubMed ID: 34275251
[No Abstract] [Full Text] [Related]
12. Clinicopathological characteristics and prognostic value of cancer stem cell marker CD133 in breast cancer: a meta-analysis.
Li Z; Yin S; Zhang L; Liu W; Chen B; Xing H
Onco Targets Ther; 2017; 10():859-870. PubMed ID: 28243121
[TBL] [Abstract][Full Text] [Related]
13. Factors That Predict Biological Aggressiveness in Estrogen Receptor-Positive / Human Epidermal Growth Factor Receptor 2-Negative / Lymph Node-Negative Breast Cancer.
Arthur LE; McMann AH; Slattery LN; Fuhrman GM; Mackey AM; Rivere AE; Corsetti RL
Ochsner J; 2020; 20(4):381-387. PubMed ID: 33408575
[No Abstract] [Full Text] [Related]
14. The Clinical and Molecular Characteristics of Sex-Determining Region Y-Box 2 and its Prognostic Value in Breast Cancer: A Systematic Meta-Analysis.
Zhao G; Wang X; Qu L; Zhu Z; Hong J; Hou H; Li Z; Wang J; Lv Z
Breast Care (Basel); 2021 Feb; 16(1):16-26. PubMed ID: 33716628
[TBL] [Abstract][Full Text] [Related]
15. The clinicopathological parameters and prognostic significance of HER2 expression in gastric cancer patients: a meta-analysis of literature.
Lei YY; Huang JY; Zhao QR; Jiang N; Xu HM; Wang ZN; Li HQ; Zhang SB; Sun Z
World J Surg Oncol; 2017 Mar; 15(1):68. PubMed ID: 28327158
[TBL] [Abstract][Full Text] [Related]
16. The clinical significance of platelet-derived growth factors (PDGFs) and their receptors (PDGFRs) in gastric cancer: A systematic review and meta-analysis.
Qian H; Appiah-Kubi K; Wang Y; Wu M; Tao Y; Wu Y; Chen Y
Crit Rev Oncol Hematol; 2018 Jul; 127():15-28. PubMed ID: 29891108
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological characteristics of metaplastic breast cancer - analysis of the basic immunohistochemical profile and comparison with other invasive breast cancer types.
Budzik MP; Patera J; Sobol M; Czerw AI; Deptała A; Badowska-Kozakiewicz AM
Breast; 2019 Feb; 43():135-141. PubMed ID: 30553188
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological Characteristics of Mucinous Breast Cancer: A Retrospective Analysis of a 10-Year Study.
Lei L; Yu X; Chen B; Chen Z; Wang X
PLoS One; 2016; 11(5):e0155132. PubMed ID: 27232881
[TBL] [Abstract][Full Text] [Related]
19. [Expression of estrogen receptor, progesterone receptor, and human epithelial growth factor receptor 2 in breast cancer and the significance thereof: analysis of 910 cases].
Liu RB; Zhou XH; Wang JN; Liang HZ; Li XX; Wu ZH; Ye JL; Wang SM
Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(48):3397-400. PubMed ID: 19159568
[TBL] [Abstract][Full Text] [Related]
20. Estrogen and Progesterone Receptor Expression in Breast Carcinoma and Its Association With Clinicopathological Variables Among the Pakistani Population.
Sohail SK; Sarfraz R; Imran M; Kamran M; Qamar S
Cureus; 2020 Aug; 12(8):e9751. PubMed ID: 32944466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
